3m Health Care, Ltd. v. Richard R. Grant, Administrator, Pharmacy Program, Florida Department of Health and Rehabilitative Services, State of Florida

908 F.2d 918, 1990 U.S. App. LEXIS 13733, 1990 WL 104159
CourtCourt of Appeals for the Eleventh Circuit
DecidedAugust 13, 1990
Docket89-6100
StatusPublished
Cited by3 cases

This text of 908 F.2d 918 (3m Health Care, Ltd. v. Richard R. Grant, Administrator, Pharmacy Program, Florida Department of Health and Rehabilitative Services, State of Florida) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eleventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
3m Health Care, Ltd. v. Richard R. Grant, Administrator, Pharmacy Program, Florida Department of Health and Rehabilitative Services, State of Florida, 908 F.2d 918, 1990 U.S. App. LEXIS 13733, 1990 WL 104159 (11th Cir. 1990).

Opinion

*919 FLOYD R. GIBSON, Senior Circuit Judge:

Appellant, 3M Health Care, Ltd. (“3M”), sued the State of Florida and others in federal district court, seeking declaratory and injunctive relief from compliance with Florida’s Drug and Cosmetic Act in its warehousing activities in the Port Everglades Foreign Trade Zone. 3M argued that the state law was preempted by the Foreign Trade Zones Act. The district court disagreed, granted summary judgment to Florida, and dismissed 3M’s action. We reverse on the grounds that the Florida law as applied in this factual situation frustrates the congressional intent behind the Foreign Trade Zones Act.

I. FACTS

Because the case has come to us on appeal of summary judgment, we construe the facts in the light most favorable to 3M, the Appellant. Stephens v. Department of Health and Human Services, 901 F.2d 1571, 1573 (11th Cir.1990). 3M Health Care, Ltd. is a British subsidiary of the 3M Corporation headquartered in St. Paul, Minnesota. 3M Riker U.K. is the name under which 3M Health Care, Ltd. does business in the Port Everglades Foreign Trade Zone (the “zone”) in Florida.

Foreign trade zones were created by the Foreign Trade Zones Act of 1934. 1 The act authorizes a board to create trade zones at ports of the United States through which goods can pass without being subject to United States customs duties. See 19 U.S.C. § 81c (1988); Nissan Motor Mfg. Corp., U.S.A. v. United States, 884 F.2d 1375, 1376 (Fed.Cir.1989). The purpose of the act is simple and express: “[t]o provide for the establishment, operation, and maintenance of foreign-trade zones in ports of entry of the United States, to expedite and encourage foreign commerce, and for other purposes.” Foreign Trade Zones Act, ch. 590, 48 Stat. 998 (1934). Though the goods in a zone are exempt from customs duties, the Customs Service is present in the zones to oversee their operation. See Foreign Trade Zones, 19 C.F.R. § 146.3 (1989); A.T. Cross Co. v. Sunil Trading Corp., 467 F.Supp. 47, 51 (S.D.N.Y.1979).

Since 1982, 3M Riker U.K. has transshipped pharmaceutical and other products through the zone at Port Everglades, Florida, to Latin American and Caribbean countries. 3M Riker U.K. does not manufacture any of the goods, but other 3M affiliates do. 3M Riker U.K. uses the zone for storage, handling, repackaging, and shipping of the goods. Purchasers in Latin America and the Caribbean send orders to a 3M office in Miami, Florida, which sends the order information to 3M Riker U.K. headquarters in Britain. The orders are then filled and shipped from the 3M warehouse in the zone.

3M does not ship any of the pharmaceutical goods from the zone into the United States for domestic sale. In fact, none of them are approved for sale in the United States by the Food & Drug Administration. Only one of the goods is manufactured in the United States — by a Californian affiliate of 3M. That product, like all the others, is only transshipped through the zone for Latin American purchasers.

In November of 1988, the Florida Department of Health and Rehabilitative Services, pursuant to Florida law, served 3M Riker U.K. with notice that it intended to enter and inspect the 3M warehouse in the zone to determine compliance with Florida’s Drug & Cosmetic Act. 2 Florida again *920 served notice on 3M Riker U.K. in December of 1988 and in March of the following year. Florida took the view that 3M had to be licensed as a drug wholesaler under Florida law to conduct its operations in the zone. 3M, of course, took the contrary view and so indicated in a letter to the state’s Pharmacy Program Administrator in January of 1989.

Finally, on Friday, March 24, 1989, Florida served 3M with an administrative subpoena requiring the company to appear the following Monday by representative with certain documents concerning the pharmaceuticals shipped through the zone. 3M did not comply with the subpoena, but instead filed this action in federal district court on March 31, 1989. 3M sued the State of Florida, its Department of Health and Rehabilitative Services, and the Administrator of the Department’s Pharmacy Program, Richard Grant. 3M’s complaint asked for a declaratory judgment that the Florida law was preempted by the Foreign Trade Zones Act and for appropriate injunctive relief. Defendant Grant responded by general denial, while the State and its Department of Health and Rehabilitative Services sought to dismiss 3M’s action against them based on Eleventh Amendment immunity. 3

The case went to summary judgment consideration by the district court after cross-motions by the parties. The district court concluded that Florida’s regulation of pharmaceuticals flowing into its commerce under the Drug & Cosmetic Act was a valid exercise of police power not preempted by the Foreign Trade Zones Act. 3M took this appeal.

II. ANALYSIS

This case presents the familiar and necessary problem that arises from the conflict between concurrent state and federal jurisdiction. Its resolution implicates the principles of federalism. While our nation operates as a republic of individual states, when a conflict arises between the laws of a state and the nation, the law of the nation controls. Supremacy Clause, U.S. Const, art. VI. Though the analysis is more complicated than that, we believe this case resolves itself on rather simple facts. The question to be answered is whether 3M must, within a foreign trade zone, abide by Florida’s Drug & Cosmetic Act in its warehousing of export-only pharmaceuticals. If federal law preempts the state law, 3M need not meet the state requirements.

The law of preemption was explained in a recent case from this court:

Federal law may preempt state law in three ways. First, Congress, in drafting a statute, may use language that dictates the extent to which the statute preempts state law. Second, despite the absence of such language, the wording of the statute or its legislative history may evince Congress’ intent to occupy a given regulatory field to the exclusion of state law. Third, even when Congress has not occupied the entire regulatory field, federal law nevertheless may implicitly preempt state law to the extent that state law conflicts with a federal regulatory scheme.

Taylor v. General Motors Corp., 875 F.2d 816, 822 (11th Cir.1989) (citations omitted), cert. denied, — U.S.-, 110 S.Ct. 1781, 108 L.Ed.2d 783 (1990).

The first two kinds of preemption are not applicable in this case.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
908 F.2d 918, 1990 U.S. App. LEXIS 13733, 1990 WL 104159, Counsel Stack Legal Research, https://law.counselstack.com/opinion/3m-health-care-ltd-v-richard-r-grant-administrator-pharmacy-program-ca11-1990.